Characterization of 10 vulvar carcinoma cell lines by karyotyping, comparative genomic hybridization and flow cytometry

Gynecologic Oncology

Volumn 93, Issue 1, 2004, Pages 155-163

  Raitanen, Misa ^a   Worsham, Maria J ^b   Lakkala, Taina ^a   Carey, Thomas E ^c   Van Dyke, Daniel L ^b   Grénman, Reidar ^a   Klemi, Pekka ^a   Rantanen, Virpi ^d   Isola, Jorma ^e   Grénman, Seija ^a,f  

^a UNIVERSITY OF TURKU   (Finland)

^b HENRY FORD HEALTH SYSTEM   (United States)

^c UNIVERSITY OF MICHIGAN COMPREHENSIVE CANCER CENTER   (United States)

^d TURKU CITY HOSPITAL   (Finland)

^e TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^f TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

CGH; Characterization; Chromosomal aberrations; Cytogenetics; Squamous cell carcinoma; Vulvar carcinoma

Indexed keywords

BLEOMYCIN; GENOMIC DNA;

ADULT; AGED; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CANCER GENETICS; CANCER GROWTH; CELL TYPE; CHROMOSOME 11P; CHROMOSOME 11Q; CHROMOSOME 18Q; CHROMOSOME 3P; CHROMOSOME 3Q; CHROMOSOME 8P; CHROMOSOME 8Q; CHROMOSOME ARM; CHROMOSOME G BAND; CHROMOSOME LOSS; CHROMOSOME NUMBER; CHROMOSOME REARRANGEMENT; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DIPLOIDY; DNA CONTENT; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; KARYOTYPE; KARYOTYPING; MOUSE; NONHUMAN; PRIORITY JOURNAL; VULVA CARCINOMA;

ADULT; AGED; ANIMALS; CARCINOMA, SQUAMOUS CELL; CELL DIVISION; CELL LINE, TUMOR; CHICKENS; CHROMOSOME ABERRATIONS; DNA, NEOPLASM; FEMALE; FLOW CYTOMETRY; GENE DOSAGE; HUMANS; KARYOTYPING; MICE; MICE, NUDE; MIDDLE AGED; NUCLEIC ACID HYBRIDIZATION; TROUT; VULVAR NEOPLASMS;

EID: 12144288074     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ygyno.2003.12.033     Document Type: Article

References (37)

1. Madeleine M.M., Daling J.R., Carter J.J., Wipf G.C., Schwartz S.M., McKnight B.et al. Cofactors with human papillomavirus in a population-based study of vulvar cancer. J. Natl. Cancer Inst. 20:1997;1516-1523.
2. Al-Ghamdi A., Freedman D., Miller D., Poh C., Rosin M., Zhang L.et al. Vulvar squamous cell carcinoma in young women: a clinicopathologic study of 21 cases. Gynecol. Oncol. 84:2002;94-101.
3. Bloss J.D., Liao S.-Y., Wilczynski S.P., Macri C., Walker J., Peake M.et al. Clinical and histologic features of vulvar carcinomas analyzed for human papillomavirus status: evidence that squamous cell carcinoma of the vulva has more than one etiology. Hum. Pathol. 22:1991;711-718.
4. Hording U., Junge J., Daugaard S., Lundvall F., Poulsen H., Bock J.E. Vulvar squamous cell carcinoma and papillomaviruses: indications for two different etiologies. Gynecol. Oncol. 52:1994;241-246.
5. Kagie M.J., Kenter G.G., Zomerdijk-Nooijen Y., Hermans J., Schuuring E., Timmers P.J.et al. Human papillomavirus infection in squamous cell carcinoma of the vulva, in various synchronous epithelial changes and in normal vulvar skin. Gynecol. Oncol. 67:1997;178-183.
6. Crum C.P. Carcinoma of the vulva: epidemiology and pathogenesis. Obstet. Gynecol. 79:1992;448-454.
7. Hietanen S.H., Grénman S., Syrjänen K., Lappalainen K., Kauppinen J., Carey T.et al. Human papillomavirus in vulvar and vaginal carcinoma cell lines. Br. J. Cancer. 72:1995;134-139.
8. Thorland E.C., Myers S.L., Persing D.H., Sarkar G., McGovern R.M., Gostout B.S.et al. Human papillomavirus type 16 integrations in cervical tumors frequently occur in common fragile sites. Cancer Res. 60:2000;5916-5921.
9. Grénman S.E., Van Dyke D.L., Worsham M.J., England B., McClatchey K.D., Hopkins M.et al. Phenotypic characterization, karyotype analysis and in vitro tamoxifen sensitivity of new er-negative vulvar carcinoma cell lines, UM.SCV-1A and UM-SCV-1B. Int. J. Cancer. 45:1990;920-927.
10. Worsham M.J., Van Dyke D.L., Grénman S.E., Grénman R., Hopkins M.P., Roberts J.A.et al. Consistent chromosome abnormalities in squamous cell carcinoma of the vulva. Genes, Chromosomes Cancer. 3:1991;420-432.
11. Mitelman F. Catalogue of chromosome aberrations in cancer. Fifth ed. 1994;Wiley-Liss, Inc. New York.
12. Carpenter P.M., Gamboa-Vujicic G., Mascarello J.T., Wilczynski S., Bhaumik M., Dorion G.et al. UCI-VULV-1, a vulvar squamous carcinoma cell line. Gynecol. Oncol. 57:1995;191-198.
13. Teixeira M.R., Kristensen G.B., Abeler V.M., Heim S. Karyotypic findings in tumors of the vulva and vagina. Cancer Genet. Cytogenet. 111:1999;87-91.
14. Kallioniemi O.-P., Kallioniemi A., Piper J., Isola J., Waldman F.M., Gray J.W.et al. Optimizing comparative genomic hybridization or analysis of DNA sequence copy number changes in solid tumors. Genes, Chromosomes Cancer. 10:1994;231-243.
15. Carey T.E. Establishment of epidermoid carcinoma cell lines. Head and neck carcinoma. 1985;Wiley, Inc. New York.
16. Grénman R., Burk D., Virolainen E., Wagner J.G., Lichter A.S., Carey T.E. Radiosensitivity of head and neck cancer cells in vitro. Arch. Otolaryngol., Head Neck Surg. 114:1988;427-431.
17. ISCN Mitelman F. An international system for human cytogenetic nomenclature. 1995;S. Karger, Basel. Suppl.
18. Piper J., Rutovitz D., Sudar D., Kallioniemi A., Kallioniemi O.-P., Waldman F.M.et al. Computer image analysis of comparative genomic hybridization. Cytometry. 19:1995;10-26.
19. Braakhuis B.J.M., Sneeuwloper G., Snow G.B. The potential of the nude mouse xenograft model for the study of head and neck cancer. Arch. Oto-Rhino-Laryngol. 239:1984;69-79.
20. Alanen K., Klemi P.J., Taimela S., Joensuu H. A simple preservative for flow cytometric DNA analysis. Cytometry. 10:1989;86-89.
21. Vindeløv L.L., Christensen I.J., Nissen N.I. A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometry. 3:1983;323-327.
22. Worsham M.J., Carey T.E., Benninger M.S., Van Dyke D.L. Clonal cytogenetic evolution in a squamous cell carcinoma of the skin from a xeroderma pigmentosum patient. Genes, Chromosomes Cancer. 7:1993;158-164.
23. Steinardottir M., Jonasson J.G., Petursdottir I., Sigurdsson H., Ogmundsdottir H.M. A comparison of cytogenetic studies and flow cytometry in breast carcinomas. Cytometry. 28:1997;323-328.
24. Akervall J., Jin Y., Baldetorp B., Mertens F., Wennerberg J. Complex karyotypes in flow cytometrically DNA-diploid squamous cell carcinomas of the head and neck. Br. J. Cancer. 7:1998;1082-1088.
25. Tanner M.M., Grénman S., Koul A., Johannsson O., Meltzer P., Pejovic T.et al. Frequent amplification of chromosomal region 20q12-q13 in ovarian cancer. Clin. Cancer Res. 6:2000;1833-1839.
26. Jee K.J., Kim Y.T., Kim K.R., Kim H.S., Yan A., Knuutila S. Loss in 3p and 4p and gain of 3q are concomitant aberrations in squamous cell carcinoma of the vulva. Mod. Path. 5:2001;377-381.
27. Allen D.G., Hutchins A.M., Hammet F., White D.J., Scurry J.P., Tabrizi S.N.et al. Genetic aberrations detected by comparative genomic hybridisation in vulvar cancers. Br. J. Cancer. 6:2002;924-928.
28. Heselmeyer K., Schrock E., du Manoir S., Blegen H., Shah K., Steinbeck R.et al. Gain of chromosome 3q defines the transition from severe dysplasia to invasive carcinoma of the uterine cervix. Proc. Natl. Acad. Sci. 1:1996;479-484.
29. Heselmeyer K., du Manoir S., Blegen H., Friberg B., Svensson C., Schrock E.et al. A recurrent pattern of chromosomal aberrations and immunophenotypic appearance defines anal squamous cell carcinomas. Br. J. Cancer. 10:1997;1271-1278.
30. Bergamo N.A., Rogatto S.R., Poli-Frederico R.C., Reis P.P., Kowalski L.P., Zielenska M.et al. Comparative genomic hybridization analysis detects frequent over-representation of DNA sequences at 3q, 7p and 8q in head and neck carcinomas. Cancer Genet. Cytogenet. 119:2000;48-55.
31. Rantanen V., Grénman S., Kurvinen K., Hietanen S., Raitanen M., Syrjänen S. p53 Mutations and presence of HPV DNA do not correlate with radiosensitivity of gynecological cancer cell lines. Gynecol. Oncol. 71:1998;352-358.
32. Tirkkonen M., Tanner M., Karhu R., Kallioniemi A., Isola J., Kallioniemi O.P. Molecular cytogenetics of primary breast cancer by CGH. Genes, Chromosomes Cancer. 21:1998;177-184.
33. Kirchhoff M., Rose H., Petersen B.L., Maahr J., Gerdes T., Lundsteen C. et al. Comparative genomic hybridization reveals a recurrent pattern of chromosomal aberrations in severe dysplasia/carcinoma in situ of the cervix and in advanced-stage cervical carcinoma. Genes, Chromosomes Cancer. 24:1999;144-150.
34. Frank C.J., McClatchey K.D., Devaney K.O., Carey T.E. Evidence that loss of chromosome 18q is associated in tumor progression. Cancer Res. 57:1997;824-827.
35. Carey T.E., Van Dyke D.L., Worsham M.J. Nonrandom chromosome aberrations and clonal populations in head and neck cancer. Anticancer Res. 13:1993;2561-2567.
36. Bockmuhl U., Wolf G., Schmidt S., Schwendel A., Jahnke V., Dietel M.et al. Genomic alterations associated with malignancy in head and neck cancer. Head Neck. 20:1998;145-151.
37. Mertens F., Johansson B., Höglund M., Mitelman F. Chromosome imbalance maps of malignant solid tumors: a cytogenetic survey of 3185 neoplasms. Cancer Res. 57:1997;2765-2780.